Tower Research Capital (TRC)’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,055	Closed	-$9K	–	7069
2022 Q1	$9K	Sell	3,055 -37,723	-93%	-$83K	﹤0.01%	4545
2021 Q4	$52K	Buy	40,778 +24,028	+143%	+$48.2K	﹤0.01%	2739
2021 Q3	$38K	Buy	16,750 +12,428	+288%	+$44.7K	﹤0.01%	3189
2021 Q2	$25K	Buy	4,322 +3,289	+318%	+$21.9K	﹤0.01%	3710
2021 Q1	$6K	Buy	1,033 +882	+584%	+$6.62K	﹤0.01%	4635
2020 Q4	$1K	Buy	151 +54	+56%	+$477	﹤0.01%	5076
2020 Q3	$1K	Sell	97 -391	-80%	-$4.03K	﹤0.01%	4767
2020 Q2	$5K	Buy	+488	New	+$4.83K	﹤0.01%	4317

Tower Research Capital (TRC)'s TLMD Position: Q2 2022 in Review

Tower Research Capital (TRC) sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 3,055 shares — an estimated $9K sold.

Tower Research Capital (TRC) first reported a position in TLMD in Q2 2020 and held it in 8 quarters. The position peaked at $52K in Q4 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Tower Research Capital (TRC) reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 3,055 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $9K.
Tower Research Capital (TRC) first reported a position in SOC Telemed, Inc. Class A Common Stock in Q2 2020 and held it in 8 quarters.
Tower Research Capital (TRC)'s SOC Telemed, Inc. Class A Common Stock position peaked at $52K in Q4 2021.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.